Brief: Cipla Enters JV With Kemwell Biopharma For Biologic Products
02/03/2026 15:24
March 2 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - ENTERS 60:40 JOINT VENTURE WITH KEMWELL BIOPHARMA CIPLA - JOINT VENTURE TO DEVELOP AND COMMERCIALIZE BIOLOGIC PRODUCTS CIPLA - JV PARTNERS TO INVEST UP TO 100 MILLION RUPEES IN THEIR RESPECTIVE JV RATIO Source text: ID:nBSE90frGn Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated